The cytopathology of soft tissue mxyomas: Ganglia, juxta-articular myxoid lesions, and intramuscular myxoma

Department of Pathology, The Ohio State University College of Medicine, Columbus, 43210, USA.
American Journal of Clinical Pathology (Impact Factor: 2.51). 07/2005; 123(6):858-65. DOI: 10.1309/39YX-94KX-T0T2-CNUX
Source: PubMed

ABSTRACT We studied the practicality of issuing a cytologic diagnosis of myxoma/juxta-articular myxoid lesion/ganglion (MJG) by reviewing all fine-needle aspiration (FNA) biopsy specimens of soft tissue masses in our files with diagnoses of myxoma, myxoid cyst, myxoid lesion, ganglion, or ganglion cyst. The control group was soft tissue aspirates with abundant myxoid stroma. Of 39 cases with a cytologic diagnosis of soft tissue MJG, 15 had subsequent tissue biopsy or complete resection of the mass; 24 had clinicoradiologic follow-up. All cases except 1 (fat necrosis) were diagnosed correctly as benign myxoid lesions. We grouped MJG aspirates into 3 subtypes based on clinicoradiologic features: soft tissue ganglion/ganglion cyst (12 cases), juxta-articular myxoid lesion (16 cases), and intramuscular myxoma (11 cases). MJG aspirates showed few, subtle cytopathologic differences among subtypes. They characteristically had a viscous, gelatinous quality when expressed from the needle onto the glass slide. The typical smear contained a film of paucicellular, often finely granular, myxoid stroma, that contained few cells, usually macrophages or bland spindle cells. Control group aspirates always contained cellular components that allowed distinction from MJGs. The cytopathologic diagnosis of MJG lesions is accurate; FNA biopsy can be used to subtype MJGs into 3 categories when clinicoradiologic features are known.

Download full-text


Available from: Joel Mayerson, Sep 26, 2015
54 Reads
  • Source
    • "IM has an incidence of 0.1 to 0.3 per 100,000 [1]. According to the World Health Organization, IM is classified as a tumor of uncertain differentiation [2]. The symptoms, if any, are usually vague. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Intramuscular myxoma is a rare benign soft tissue tumor. The lack of specific symptoms and widely used laboratory tests makes the diagnosis quite difficult. We present a case of an Intramuscular myxoma associated with an increased carbohydrate antigen 19.9 level. To the best of our knowledge, there have not been any reported cases of an association of Intramuscular myxoma with tumor markers in the literature. A 45-year-old Caucasian woman presented to our department for resection of a mass in her left groin area, discovered incidentally on a triplex ultrasonography of her lower extremities. The diagnosis of Intramuscular myxoma was confirmed on histopathology after the complete surgical excision of the tumor. On laboratory examination, the serum level of carbohydrate antigen 19.9 was found to be elevated, but it returned to normal six months after resection of the mass. Carbohydrate antigen 19.9 is a tumor marker that increases in a variety of malignant and benign conditions. After the exclusion of all other possible reasons for carbohydrate antigen 19.9 elevation, we assumed a possible connection of carbohydrate antigen 19.9 elevation and Intramuscular myxoma, an issue that requires needs further investigation.
    Journal of Medical Case Reports 05/2011; 5(1):184. DOI:10.1186/1752-1947-5-184
  • [Show abstract] [Hide abstract]
    ABSTRACT: Soft tissue swelling represents a common clinical sign of a variety of neoplastic and non-neoplastic lesions. Sarcoma is rarely a cause. Fine needle biopsy as a minimally invasive, economic and accurate method is well suited for the diagnosis of inflammatory/infectious processes as well as of recurrent and metastatic disease. Cytologic diagnosis of primary soft tissue tumors is also feasible. It requires close collaboration with other medical disciplines and incorporation of clinical, radiological and morphologic findings. Clinical data such as age, gender, size and topography are important parameters. The differentiation of cells and properties of the extracellular matrix supplies clues for the differential diagnosis and forms the starting point for immunohistochemical or molecular analysis (FISH, RT-PCR). This analysis may be performed on cytological smears, paraffin embedded material of the cell blocks or on frozen material.
    Der Pathologe 02/2010; 32(1):14-23. DOI:10.1007/s00292-010-1396-9 · 0.39 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Introducción. La tumoraciones no pulsátiles inguinales son tratadas por cirujanos vasculares por su relación con los vasos femorales. El mixoma intramuscular es un caso raro de tumor benigno con tendencia a la compresión de las estructuras vecinas y con potencial de recidiva local. La resección completa con márgenes amplios es el tratamiento indicado para ellos. Caso clínico. Varón de 57 años. Clínica de parestesias en cara anteriomedial del muslo izquierdo, ausencia de patología vascular en la extremidad afectada. En la exploración, se palpa una masa inguinal bien delimitada, blanda, compresible, no fluctuante, adherida a planos profundos, no dolorosa a la palpación, de 10 cm de diámetro. En el estudio radiológico mediante tomografía axial computarizada y resonancia magnética, se demuestra una colección líquida de contorno liso y bien definido, en íntimo contacto con el músculo psoasilíaco que se prolonga por encima del anillo inguinal con imagen en ¿reloj de arena¿ con desplazamiento de vasos femorales y sospecha diagnóstica de bursitis. Tras la resección quirúrgica, el estudio anatomopatológico es compatible con el diagnóstico de mixoma intramuscular. Conclusión. Se trata de la primera descripción en la literatura de este tumor en esta localización anatómica y con la forma en ¿reloj de arena¿ a través del anillo inguinal. Constituye una posibilidad a tener en cuenta en tumores de partes blandas en la región inguinal.
    Angiología 01/2005; 57(6). DOI:10.1016/S0003-3170(05)74941-5
Show more